Results anticipated in H2 2022 NEWTON, Mass., March 30, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics…
VANCOUVER, Washington, March 30, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the…
STOUGHTON, Mass., March 30, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced…
Ji’an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
The Company also Plans on Sharing INKmune™ Patient Case Studies Boca Raton, Florida, March 30,…
WALTHAM, Mass., March 30, 2022 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
BOSTON, March 30, 2022 (GLOBE NEWSWIRE) — PepGen, Inc., advancing the next generation of oligonucleotide…
VYN201 demonstrated statistically significant improvement in treatment response for both endpoints at 1mg/kg and 10mg/kg doses…
All enrolled patients were 2nd line metastatic non-small cell lung carcinoma (NSCLC) patients that had…
Highlights: 10 subjects in cohort four intravenously dosed; RECCE® 327 at 1,000mg, indicating to be…
– First therapeutic candidate for the treatment of SSc-ILD targeting both key fibrotic and inflammatory…
Confirmatory trial’s completion is expected in an accelerated timeline of four years with patient screening…
– Full Year 2021 Total Revenue Growth of 48%, and 11% in Core Business Segments,…
LEAMINGTON, Ontario, March 30, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray Brands” or the…
– Well capitalized from $52 million IPO and $169 million in grant funding –– Established…
WAYNE, Pa., March 30, 2022 (GLOBE NEWSWIRE) — Elemica, Inc. announced today that its Enterprise…
New FTK Imager Sessions Boost Success Rate in Fighting Crime with Forensic Data PORTLAND, Ore.,…
Choreo GA release helps teams take digital apps from ideation to production in days; adds…
SANTA CLARA, Calif., March 30, 2022 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”,…
SAN FRANCISCO, March 30, 2022 (GLOBE NEWSWIRE) — Zenput announced today that more than 5,000…